仁和品牌怎么样 申请店铺

我要投票 仁和在中草药行业中的票数:404 更新时间:2025-04-26
仁和是哪个国家的品牌?「仁和」是仁和(集团)发展有限公司旗下著名品牌。该品牌发源于江西,由创始人杨文龙在2001期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力仁和品牌出海!通过在本页面挂载仁和品牌的产品链接和联系方式,可以提高仁和产品曝光!跨境电商爆单神器,目前只要100元/年哦~

仁和怎么样

仁和(集团)发展有限公司组建于2001年,在党和各级政府的亲切关怀及社会各界的热心帮助下,通过全体员工的艰苦奋斗,现已发展成为一家集药品、保健品生产销售于一体的现代医药企业集团。目前,仁和集团旗下拥有“仁和药业股份有限公司”(证券代码:000650)等多家子公司,员工5000余人。

自创业以来,仁和集团在销售收入、贡献税收等主要经济指标方面,实现了连续6年翻番增长,10年增长66倍的骄人业绩。

仁和工业企业拥有占地总面积40余万平方米的现代化生产基地,注册生产中西药品、保健品等200多个品种,已有胶囊剂、软胶囊剂、滴丸剂、滴眼剂、颗粒剂、片剂、洗剂、橡胶膏剂等29个药品剂型和8个保健食品剂型获得国家GMP认证证书,形成了药品、保健品两大类产品生产板块。

凭籍雄厚的科研实力,仁和集团先后研制、开发了200多个医药、保健产品。仁和集团的“中药集成创新技术平台”项目获得国家资金支持,集团公司被评定为“省级企业技术中心”,所属药都仁和制药、闪亮制药两家公司被双双认定为国家级高新技术企业。目前,仁和集团拥有一支以博士、硕士为主体的技术研发核心团队,并与中国中医药科学院等多家科研院所建立了战略合作关系。仁和集团独立研发的“仁和健心胶囊”产品被列为国家“863”高科技项目,填补了江西省医药“863”高科技项目的空白。

通过成功的市场运作,仁和集团建立了品牌打造的核心竞争力,现已形成由仁和企业品牌和5个主导产品品牌组成的品牌集群。其中,由仁和集团独立研发并享有知识产权的“妇炎洁”系列产品,已经成为中国女性保健护卫市场的领袖品牌产品。仁和牌“优卡丹”、“仁和可立克”、“清火胶囊”,闪亮牌“萘敏维滴眼液”、“复方门冬维甘滴眼液”等产品也都是国内同类产品中的名牌产品。

继“仁和”商标于2007年9月被国家工商总局认定为“中国驰名商标”后,2008年4月,“闪亮”商标经司法认定为“中国驰名商标”。2009年6月,“妇炎洁”第5类商标获得国家商标管理局批准注册。

优质的产品和遍布全国30个省、市、自治区的营销网络,是仁和商业凸显市场竞争力的坚实基础。先进的市场营销和营销管理模式、大规模的广告支持、周到的售后服务、快速有力的物流保障,构成了仁和商业“争天时,取地利,倡人和”的经营特色。

饮水思源,回报社会,是仁和企业与全体员工的共同信念。2006年7月,仁和集团全资赞助了中国第一所“希望医院”——“仁和希望医院”。2008年冻雪灾害期间,仁和集团派出专业工作队奔赴重灾区抢修电力设施。四川省汶川地区遭受特大地震灾害后,仁和集团在江西省率先发起赈灾捐助,企业与员工共计捐助现金和物资近700万元。2009年,仁和集团为昌樟高速公路暨赣江“双桥”建设工程捐资888万元,向江西省“青苗关爱工程”、“仁和博爱送万家”等公益事业和新农村建设等捐款共计300余万元。

自组建以来,仁和集团向“希望工程”、“希望医院”、抢险救灾、修桥筑路及社会弱势群体捐款、捐物累计价值逾4000万元,安置下岗职工和农村剩余劳动力就业近5000人次,受到党和政府及社会各界的充分肯定与高度赞扬,获得多项荣誉称号。

Renhe (Group) Development Co., Ltd. was established in 2001. With the cordial care of the party and governments at all levels and the enthusiastic help of all sectors of society, through the hard work of all employees, it has developed into a modern pharmaceutical enterprise group integrating the production and sales of drugs and health care products. At present, Renhe group has many subsidiaries including "Renhe Pharmaceutical Co., Ltd" (securities code: 000650), with more than 5000 employees. Since its establishment, Renhe group has achieved six consecutive years of double growth in terms of sales revenue, contribution tax and other major economic indicators, and 66 times of growth in 10 years. Renhe Industrial enterprise has a modern production base covering a total area of more than 400000 square meters, registered to produce more than 200 varieties of Chinese and Western medicine and health products, and has 29 pharmaceutical formulations such as capsules, soft capsules, dropping pills, eye drops, granules, tablets, lotions, rubber plasters and 8 health food formulations, which have obtained the national GMP certificate, forming two major pharmaceutical and health products Class a product production section. With strong scientific research strength, Renhe group has developed more than 200 medical and health care products. Renhe group's "integrated innovation technology platform for traditional Chinese medicine" project was supported by national funds. The group company was rated as "provincial enterprise technology center", and its pharmaceutical capital Renhe pharmaceutical and shinning pharmaceutical were both recognized as national high-tech enterprises. At present, Renhe group has a core technology R & D team with doctors and masters as the main body, and has established strategic cooperation with many scientific research institutes such as China Academy of traditional Chinese medicine and pharmacy. Renhe Jianxin capsule, independently developed by Renhe group, is listed as the national "863" high-tech project, which fills the gap in the "863" high-tech project of Jiangxi medicine. Through successful market operation, Renhe group has established the core competitiveness of brand building, and now has formed a brand cluster consisting of Renhe enterprise brand and five leading product brands. Among them, "fuyanjie" series products independently developed by Renhe group and enjoying intellectual property rights have become the leading brand products in China's women's health care market. Renhe brand "ucadan", "Renhe Kerik", "Qinghuo capsule", shinning brand "naphthalene sensitive eye drops", "compound menthol Wigan eye drops" and other products are also famous brand products in domestic similar products. After Renhe trademark was recognized as "China's well-known trademark" by the State Administration of industry and Commerce in September 2007, shinning trademark was recognized as "China's well-known trademark" by judicial authorities in April 2008. In June 2009, "fuyanjie" category 5 trademark was approved for registration by the state trademark administration. The high-quality products and the marketing network covering 30 provinces, cities and autonomous regions are the solid foundation for Renhe business to highlight its market competitiveness. Advanced marketing and marketing management mode, large-scale advertising support, thoughtful after-sales service and fast and powerful logistics guarantee constitute the business characteristics of Renhe business, which is "competing for the time, taking advantage of the place and advocating harmony of people". It is the common belief of Renhe enterprise and all its employees to drink water and think of the source and repay the society. In July 2006, Renhe group wholly sponsored "Renhe Hope Hospital", the first "Hope Hospital" in China. During the snow disaster in 2008, Renhe group sent a professional team to rush to the disaster area to repair the power facilities. After the Wenchuan earthquake in Sichuan Province, Renhe group took the lead in initiating disaster relief donations in Jiangxi Province, with enterprises and employees contributing nearly 7 million yuan in cash and materials. In 2009, Renhe Group donated 8.88 million yuan for the construction of Changzhang Expressway and Ganjiang "double bridge" project, and donated more than 3 million yuan to public welfare undertakings such as "Qingmiao care project", "Renhe fraternity to send thousands of families" and new rural construction in Jiangxi Province. Since its establishment, Renhe group has donated more than 40 million yuan to "Hope Project", "Hope Hospital", rescue and relief work, bridge and road construction, social vulnerable groups, and donated goods. It has resettled laid-off workers and rural surplus labor force for nearly 5000 people. It has been fully affirmed and highly praised by the party, government and all sectors of society, and won many honorary titles.

本文链接: https://brand.waitui.com/a8f386cf6.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

埃隆·马斯克旗下XAI公司正与投资者洽谈 计划融资约200亿美元

埃隆·马斯克旗下的xAI正与投资者洽谈,为其人工智能初创公司及社交媒体业务筹集约200亿美元资金。该笔交易将使公司估值超过1200亿美元,所得资金或可用于偿还马斯克将推特私有化所产生的债务。此轮融资预计将在未来几个月内完成,且有可能筹集到超过200亿美元的资金。数据提供商PitchBook的数据显示,若此笔交易达成,将成为有史以来规模第二大的初创企业融资轮次,仅次于今年早些时候OpenAI获得的400亿美元融资。(财联社)

42分钟前

中国重汽与丰田汽车签署战略合作协议

中国重汽与丰田汽车25日在日本名古屋丰田总部签署战略合作协议。双方联合开发的氢燃料电池牵引车已批量交付市场应用。未来,双方将在氢燃料商用车合作研发、示范运营、推广应用、商业模式创新等领域建立更广泛的合作。(财联社)

42分钟前

中国人民银行行长潘功胜会见新兴市场经济体央行主要负责人

2025年4月国际货币基金组织/世界银行春季会议期间,中国人民银行行长潘功胜在美国华盛顿会见了韩国央行行长李昌镛、巴西央行行长加利波罗、南非央行行长康亚戈、阿根廷央行行长鲍希利,主要就全球经济金融形势、深化双边务实合作等议题交换了意见。 中方强调,当前全球经济复苏充满不确定性,新兴市场和发展中国家应利用日益增强的政治互信和经济互补,通过多边、双边渠道加强政策协调,推进金融务实合作,维护以多边规则为基础的全球治理秩序。(界面)

42分钟前

习近平在中共中央政治局第二十次集体学习时强调,坚持自立自强,突出应用导向,推动人工智能健康有序发展

中共中央政治局4月25日下午就加强人工智能发展和监管进行第二十次集体学习。中共中央总书记习近平在主持学习时强调,面对新一代人工智能技术快速演进的新形势,要充分发挥新型举国体制优势,坚持自立自强,突出应用导向,推动我国人工智能朝着有益、安全、公平方向健康有序发展。(新华社)

42分钟前

上海经信委:将推动整车企业转型,加强智能驾驶大模型等创新应用

“智链未来 共赢新章”2025年长三角新能源汽车产业链供应链创新合作大会于4月25日在国家会展中心(上海)召开。上海市经信委二级巡视员、汽车产业处处长韩大东在会上致辞时表示,汽车产业是上海的重点产业之一。在当前全球汽车产业变革调整窗口期、机遇期,上海全力破解汽车产业转型升级的痛点、堵点,加快打造世界级汽车产业中心,推动长三角一体化发展,近年来取得了一定成效。 韩大东强调,当前,全球汽车竞争格局向电动化、智能化、AI化发展,零部件一体化、集成化、轻量化趋势明显。叠加国际贸易摩擦、关税壁垒等地缘政治影响,汽车产业链面临重塑与变革。为加快提升长三角地区汽车产业全链条竞争力,上海将推动整车企业改革转型,加强智能驾驶大模型等创新技术应用,加快智己、奥迪、尚界等新车型投产上市,促进长三角地区及全国汽车产业链上下游协同发展。(澎湃新闻)

42分钟前

本页详细列出关于仁和的品牌信息,含品牌所属公司介绍,仁和所处行业的品牌地位及优势。
咨询